Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_assertion description "[Dukes stages C and D were more frequent in primary tumors with loss of MSH3 expression (9 of 13), compared with tumors with retained expression (1 of 14; Fisher's exact test, P = 0.001), suggesting that MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_assertion evidence source_evidence_literature NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_assertion SIO_000772 14871813 NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_assertion wasDerivedFrom befree-20150227 NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_assertion wasGeneratedBy ECO_0000203 NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP570743.RAMEHY3f0vZGxYEKgqGB_5IW3o97bQrNXx3XoxgRDMKbc130_provenance.